Breast cancer is a leading cause of death among women worldwide. Dysbiosis, an aberrant
composition of the microbiome, characterizes breast cancer. In this review we discuss the …

Simple Summary In this review we discuss the recent knowledge about the role of breast
and gut microbiome in the pathogenesis of breast cancer. We examine the proposed …

A depleted antimicrobial drug pipeline combined with an increasing prevalence of Gram-
negative 'superbugs' has increased interest in nano therapies to treat antibiotic resistance …

Pseudomonas aeruginosa is a complex gram-negative facultative anaerobe replete with a
variety of arsenals to activate, modify, and destroy host defense mechanisms. The microbe is …

Highlights•Drug combinations improve efficacy and permit dose reductions of each
drug.•Lowering the dose of combined drugs prevents concentration-associated …

The emergence of new resistance mechanisms, the failure of classical antibiotics in clinic,
the decrease in the development of antibiotics in the industry are all challenges that lead us …

This paper investigates the performance of AD in the presence of high-risk pharmaceuticals
found in sewage sludge and its removal capacity. The digestion process of synthetic sewage …

With the advent of next generation sequencing technologies, there is an increasingly
complex understanding of the role of gastrointestinal and local breast microbial dysbiosis in …

The concept of repurposing previously approved medications to the treatment of new
indications by taking advantage of off-target effects has gained traction in recent years …

Despite the significant progress in diagnosis and treatment over the past years in the
understanding of breast cancer pathophysiology, it remains one of the leading causes of …